Food and Drug Administration, HHS.
Final rule; correction.
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of March 23, 2011 (76 FR 16292). The document announced the classifying of ovarian adnexal mass assessment score test system into class II (special controls). The document was published with an incorrect docket number. This document corrects that error.
Effective: April 22, 2011.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Planning and Budget, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.End Further Info End Preamble Start Supplemental Information
In FR Doc. 2011-6620, appearing on page 16292, in the Federal Register of Wednesday, March 23, 2011, the following correction is made:
1. On page 16292, in the first column, in the Docket No. heading, “[Docket No. FDA-2011-N-0026]” is corrected to read “[Docket No. FDA-2010-N-0026].”Start Signature
Dated: April 13, 2011.
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-9649 Filed 4-20-11; 8:45 am]
BILLING CODE 4160-01-P